Skip to main content

Immune modulation by proteins secreted from cells infected by vaccinia virus

  • Chapter
100 Years of Virology

Part of the book series: Archives of Virology. Supplementa ((ARCHIVES SUPPL,volume 15))

Summary

Vaccinia virus comprises the live vaccine that was used for vaccination against smallpox. Following the eradication of smallpox, vaccinia virus was developed as an expression vector that is now used widely in biological research and vaccine development. In recent years vaccinia virus and other p oxviruses have been found to express a collection of proteins that block parts of the host response to infection. Some of these proteins are secreted from the infected cell where they bind and neutralise host cytokines, chemokines and interferons (IFN). In this paper three such proteins that bind interleukin (IL)-1β, type I IFNs and CC chemokines are described. The study of these immunomodulatory molecules is enhancing our understanding of virus pathogenesis, yielding fundamental information about the immune system, and providing new molecules that have potential application for the treatment of immunological disorders or infectious diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Aguado B, Seltnes IP, Smith GL (1992) Nucleotide sequence of 21.8 kbp of variola major virus strain Harvey and comparison with vaccinia virus. J Gen Virol 73: 2 887–2 902

    Article  CAS  Google Scholar 

  2. Alcamí A, Smith GL (1992) A soluble receptor for interleukin-IL-lβ encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71: 153–167

    Article  PubMed  Google Scholar 

  3. Alcamí A, Smith GL (1995) Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J Virol 69: 4 633–4 639

    Google Scholar 

  4. Alcamí A, Smith GL (1996) A mechanism for the inhibition of fever by a virus. Proc Natl Acad Sci USA 93: 11029–11034

    Article  PubMed  Google Scholar 

  5. Alcamí A, Symons JA, Collins PD, Williams TJ, Smith GL (1998) Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J Immunol 160: 624–633

    PubMed  Google Scholar 

  6. Amano H, Ueda Y, Tagaya I (1979) Orthopoxvirus strains defective in surface antigen induction. J Gen Virol 44: 265–269

    Article  PubMed  CAS  Google Scholar 

  7. Antoine G, Scheiflinger F, Dorner F, Falkner FG (1998) The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 244: 365–396

    Article  PubMed  CAS  Google Scholar 

  8. Baggiolini M, Dewald B, Moser B (1997) Human chemokines: an update. Annu Rev Immunol 15: 675–705

    Article  PubMed  CAS  Google Scholar 

  9. Baxby D (1981) Jenner’s smallpox vaccine. The riddle of the origin of vaccinia virus. Heinemann, London

    Google Scholar 

  10. Beattie E, Tartaglia J, Paoletti E (1991) Vaccinia-virus encoded eIF-2α homolog abrogates the antiviral effect of interferon. Virology 183: 419–422

    Article  PubMed  CAS  Google Scholar 

  11. Berger EA (1997) HIV entry and tropism: the chemokine receptor connection. AIDS 11: S3–16

    PubMed  Google Scholar 

  12. Blake NW, Kettle S, Law KM, Gould K, Bastin J, Townsend AR, Smith GL (1995) Vaccinia virus serpins B13R and B22R do not inhibit antigen presentation to class I-restricted cytotoxic T lymphocytes. J Gen Virol 76: 2 393–2 398

    Article  CAS  Google Scholar 

  13. Blanchard TJ, Alcamí A, Andrea P, Smith GL (1998) Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine. J Gen Virol 79: 1 159–1 167

    CAS  Google Scholar 

  14. Bosworth N, Towers P (1989) Scintillation proximity assay. Nature 341: 167–168

    Article  PubMed  CAS  Google Scholar 

  15. Chang H-W, Watson JC, Jacobs BL (1992) The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci USA 89: 4 825–4 829

    Google Scholar 

  16. Cochran MA, Puckett C, Moss B (1985) In vitro mutagenesis of the promoter region for a vaccinia virus gene: evidence for tandem early and late regulatory signals. J Virol 54: 30–37

    PubMed  CAS  Google Scholar 

  17. Colamonici OR, Domanski P, Sweitzer SM, Larner A, Buller RML (1995) Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling. J Biol Chem 270: 15 974–15 978

    CAS  Google Scholar 

  18. Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ (1995) Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 182: 1169–1174

    Article  PubMed  CAS  Google Scholar 

  19. Dinarello CA (1996) Biological basis for interleukin-1 in disease. Blood 87: 2 095–2 147

    CAS  Google Scholar 

  20. Fenner F, Anderson DA, Arita I, Jezek Z, Ladnyi ID (1988) Smallpox and its eradication. World Health Organisation, Geneva

    Google Scholar 

  21. Goebel SJ, Johnson GP, Perkus ME, Davis SW, Winslow JP, Paoletti E (1990) The complete DNA sequence of vaccinia virus. Virology 179: 247–266

    Article  PubMed  CAS  Google Scholar 

  22. Graham KA, Lalani AS, Macen JL, Ness TL, Barry M, Liu L, Lucas A, Clark-Lewis I, Moyer RW, McFadden G (1997) The Tl/35 kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology 229: 12–24

    Article  PubMed  CAS  Google Scholar 

  23. Horuk R, Chitnis CE, Darbonne WC, Colby TJ, Rybicki A, Hadley TJ, Miller LH (1993) A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 261: 1182–1184

    Article  PubMed  CAS  Google Scholar 

  24. Howard ST, Chan YS, Smith GL (1991 ) Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family. Virology 180: 633–647

    Article  PubMed  CAS  Google Scholar 

  25. Jenner E (1798) An enquiry into the causes and effects of variolae vaccinae, a disease discovered in some western countries of England, particularly Gloucestershire, and known by the name of cow pox. Reprinted by Cassell, 1896, London

    Google Scholar 

  26. Kozak W, Zheng H, Conn CA, Soszynski D, vander Ploeg LH, Kluger MJ (1995) Thermal and behavioral effects of lipopolysaccharide and influenza in interleukin-1 beta-deficient mice. Am J Physiol 269: 969–977

    Google Scholar 

  27. Lane JM, Ruben FL, Neff JM, Millar JD (1969) Complications of smallpox vaccination, 1968. National surveillance in the United States. N Engl J Med 281: 1 201–1 208

    CAS  Google Scholar 

  28. Liptakova H, Kontsekova E, Alcamí A, Smith GL, Kontsek P (1997) Analysis of an interaction between the soluble vaccinia virus-coded type I interferon (IFN)-receptor and human IFN-alphal and IFN-alpha2. Virology 232: 86–90

    Article  PubMed  CAS  Google Scholar 

  29. Mackett M, Smith GL, Moss B (1982) Vaccinia virus: a selectable eukaryotic cloninig and expression vector. Proc Natl Acad Sci USA 79: 7 415–7 419

    Article  CAS  Google Scholar 

  30. Mackett M, Smith GL, Moss B (1984) General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J Virol 49: 857–864

    PubMed  CAS  Google Scholar 

  31. Massung RF, Liu LI, Qi J, Knight JC, Yuran TE, Kerlavage AR, Parsons JM, Venter JC, Esposito JJ (1994) Analysis of the complete genome of smallpox variola major virus strain Bangladesh-1975. Virology 201: 215–240

    Article  PubMed  CAS  Google Scholar 

  32. McMahan CJ, Slack JL, Mosley B, Cosman D, Lupton SD, Brunton LL, Grubin CE, Wignall JM, Jenkins NA, Branan CI, Copeland NG, Huebner K, Croce CM, Cannizzarro LA, Benjamin D, Dower SK, Spriggs MK, Sims JE (1991) A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J 10: 2821–2 832

    PubMed  CAS  Google Scholar 

  33. Morikawa S, Ueda Y (1993) Characterization of vaccinia surface antigen expressed by recombinant baculovirus. Virology 193: 753–761

    Article  PubMed  CAS  Google Scholar 

  34. Moss B (1996) Poxviridae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM (eds) Fields Virology. Lippincott-Raven Press, New York, vol 2, pp 2637–2671

    Google Scholar 

  35. Moss B, Winters E, Coopper JA (1981) Deletion of a 9,000-base-pair segment of the vaccinia virus genome that encodes nonessential polypeptides. J Virol 40: 387–395

    PubMed  CAS  Google Scholar 

  36. Mossman K, Nation P, Macen J, Garbutt M, Lucas A, McFadden G (1996) Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology 215: 17–30

    Article  PubMed  CAS  Google Scholar 

  37. Mossman K, Upton C, Buller RM, McFadden G (1995) Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins. Virology 208: 762–769

    Article  PubMed  CAS  Google Scholar 

  38. Novick D, Cohen B, Rubinstein M (1994) The human interferon a/b receptor: characterization and molecular cloning. Cell 77: 391–400

    Article  PubMed  CAS  Google Scholar 

  39. Panicali D, Paoletti E (1982) Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proc Natl Acad Sci USA 79: 4 927–4 931

    Article  CAS  Google Scholar 

  40. Patel AH, Gaffney DF, Subak-Sharpe JH, Stow ND (1990) DNA sequence of the gene encoding a major secreted protein of vaccinia virus, strain Lister. J Gen Virol 71: 2013–2021

    Article  PubMed  CAS  Google Scholar 

  41. Premack BA, Schall TJ (1996) Chemokine receptors: gateways to inflammation and infection. Nature Med 2: 1 174–1 178

    CAS  Google Scholar 

  42. Shchelkunov SN, Massung RF, Esposito JJ (1995) Comparison of the genome DNA sequences of Bangladesh-1975 and India-1967 variola viruses. Virus Res 36: 107–118

    Article  PubMed  CAS  Google Scholar 

  43. Smith CA, Smith TD, Smolak PJ, Friend D, Hagen H, Gernart M, Park L, Pickup DJ, Torrance D, Mohler K, Schooley K, Goodwin RG (1997) Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits β chemokine activity yet lacks sequence homology to known chemokine receptors. Virology 236: 316–327

    Article  PubMed  CAS  Google Scholar 

  44. Smith GL, Chan YS (1991 ) Two vaccinia virus proteins structurally related to interleukin-1 receptor and the immunoglobulin superfamily. J Gen Virol 72: 511–518

    Article  PubMed  CAS  Google Scholar 

  45. Smith GL, Mackett M, Moss B (1983) Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature 302: 490–495

    Article  PubMed  CAS  Google Scholar 

  46. Smith GL, Symons JA, Alcamí A (1998) Poxviruses; interfering with interferon. Semin Virol 8: 409–418

    Article  CAS  Google Scholar 

  47. Smith GL, Symons JA, Khanna A, Vanderplasschen A, Alcamí A (1997) Vaccinia virus immune evasion. Immunol Rev 159: 137–154

    Article  PubMed  CAS  Google Scholar 

  48. Spriggs M, Hruby DE, Maliszewski CR, Pickup DJ, Sims JE, Buller RML, Vanslyke J (1992) Vaccinia and cowpox viruses encode a novel secreted interleukin-1 binding protein. Cell 71: 145–152

    Article  PubMed  CAS  Google Scholar 

  49. Symons JA, Alcamí A, Smith GL (1995) Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81: 551–560

    Article  PubMed  CAS  Google Scholar 

  50. Ueda Y, Ito M, Tagaya I (1969) A specific surface antigen induced by poxvirus. Virology 38:180-182

    Google Scholar 

  51. Ueda Y, Morikawa S, Matsuura Y (1990) Identification and nucleotide sequence of the gene encoding a surface antigen induced by vaccinia virus. Virology 177: 588–594

    Article  PubMed  CAS  Google Scholar 

  52. Ueda Y, Tagaya I (1973) Induction of skin resistance to vaccinia virus in rabbits by vaccinia-soluble early antigens. J Exp Med 138: 1 033–1 043

    Article  CAS  Google Scholar 

  53. Ueda Y, Tagaya I, Amano H, Ito M (1972) Studies on the early antigens induced by vaccinia virus. Virology 49: 794–800

    Article  PubMed  CAS  Google Scholar 

  54. Upton C, Mossman K, McFadden G (1992) Encoding of a homolog of IFN-γreceptor by myxoma virus. Science 258: 1 369–1 372

    Article  CAS  Google Scholar 

  55. Uzé G, Lutfalla G, Gresser I (1990) Genetic transfer of α functional human interferon a receptor into mouse cells: cloning and expression of its cDNA. Cell 60: 225–234

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Wien

About this chapter

Cite this chapter

Smith, G.L., Symons, J.A., Alcamí, A. (1999). Immune modulation by proteins secreted from cells infected by vaccinia virus. In: Calisher, C.H., Horzinek, M.C. (eds) 100 Years of Virology. Archives of Virology. Supplementa, vol 15. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6425-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6425-9_8

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-83360-5

  • Online ISBN: 978-3-7091-6425-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics